ARDS Clinical Trial
Official title:
Electrical Impedance Tomography (EIT) Monitoring: A Pilot Comparison to Standard of Care Assessments in Adults With Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS)
Electrical impedance tomography (EIT) monitoring has been researched as a method to
determine the spatial impedance distribution in a body cross section, but has yet to become
an established clinical tool. EIT monitoring gives a dynamic, breath-to-breath measurement
of both global and regional ventilation. Recently, there has been evidence that EIT
monitoring has great potential to become a non-invasive bedside tool for assessment of
regional lung ventilation without documented hazards. Potential applications include any
adult patients in acute respiratory failure. Data collected from this research may
contribute to improved patient safety outcomes.
PURPOSE:
The purpose of this pilot study is to examine the feasibility of using the EIT monitor in
intensive care unit (ICU) setting on patients with acute respiratory failure and to compare
the EIT monitor data to standard of care patient assessments. It is hypothesized that the
EIT monitor, when applied to adults in acute respiratory failure, will correlate with
conventional standard of care assessments for these patients.
INTRODUCTION:
Electrical impedance tomography (EIT) monitoring has been researched as a method to
determine the spatial impedance distribution in a body cross section, but has yet to become
an established clinical tool. EIT monitoring gives a dynamic, breath-to-breath measurement
of both global and regional ventilation. Recently, there has been evidence that EIT
monitoring has great potential to become a non-invasive bedside tool for assessment of
regional lung ventilation without documented hazards. Potential applications include any
adult patients in acute respiratory failure. Data collected from this research may
contribute to improved patient safety outcomes.
PURPOSE:
The purpose of this pilot study is to examine the feasibility of using the EIT monitor in
ICU setting on patients with acute respiratory failure and to compare the EIT monitor data
to standard of care patient assessments. It is hypothesized that the EIT monitor, when
applied to adults in acute respiratory failure, will correlate with conventional standard of
care assessments for these patients.
METHOD:
This pilot study design will consist of a prospective, blinded evaluation of the EIT monitor
for patients with acute lung injury or acute respiratory distress syndrome.
Once a patient has met the inclusion criteria and has signed informed consent:
1. EIT electrode chest band will be applied by trained respiratory care staff. Application
includes elastic chest band with 16 electrodes.
2. EIT electrode chest band is connected to the EIT monitor which will be turned on and
will monitor and store EIT data.
3. EIT monitoring will take place for 4 to 6 hours, during day shift (7am to 4pm)
4. Patient's may be monitored on three separate days.
No interventions, tests or modifications to the standard of care will occur to patients for
this pilot study of EIT monitoring. Clinicians guiding the care of these patients will be
blinded to the EIT data. The EIT chest band will be removed if transport of the patient is
necessary or if care is needed in the area of the chest band.
;
Intervention Model: Single Group Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04435613 -
Clinical and Physiological Assessment of a Nearly Ultra-protective Lung Ventilation Strategy: A Quasi-experimental Preliminary Study in ARDS Patients
|
N/A | |
Enrolling by invitation |
NCT05020210 -
Effect of Early Treatment With Sivelestat Sodium in ARDS Patients
|
||
Completed |
NCT04468971 -
REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia
|
Phase 1 | |
Completed |
NCT04505592 -
Tenecteplase in Patients With COVID-19
|
Phase 2 | |
Completed |
NCT04493242 -
Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS
|
Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Completed |
NCT02265198 -
Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome
|
N/A | |
Completed |
NCT01949272 -
Optimization of PEEP for Alveolar Recruitment in ARDS
|
N/A | |
Not yet recruiting |
NCT01668368 -
Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance
|
N/A | |
Completed |
NCT01881061 -
Lung Sonography in Patients With Acute Respiratory Distress Syndrome in Intensive Care Unit
|
N/A | |
Completed |
NCT00808691 -
Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit
|
N/A | |
Completed |
NCT05035589 -
The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia
|
||
Recruiting |
NCT04764032 -
Right Ventricular Dysfunction in Ventilated Patients With COVID-19
|
||
Completed |
NCT04556513 -
Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
|
||
Recruiting |
NCT06036056 -
NMR Based Metabolomics Kinetics in ARDS Patients
|
||
Recruiting |
NCT04503876 -
Effects of End-expiratory Positive Pressure Optimization in Intubated Patients With Healthy Lung or Acute Respiratory Distress Syndrome
|
N/A | |
Recruiting |
NCT04643691 -
Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS
|
Phase 2 | |
Completed |
NCT04395911 -
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections
|
N/A | |
Not yet recruiting |
NCT05341687 -
Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
|
||
Recruiting |
NCT05056090 -
Effect of Prone Positioning on Mortality in Patients With Mild to Moderate Acute Respiratory Distress Syndrome.
|
N/A |